KS Saini, MD

Will complex, individualized therapies for cancer such as CAR-Ts be manufactured at the patients bedside in future? Our editorial in @Annals_Oncology appeared in print on 1 Jan 2022. annalsofoncology.org/article/S0923-… @FAndreMD @barlesi @OncoAlert

One year later, let's take a look back at this popular #JITC review - Immuno-oncology trends: preclinical models, biomarkers, and clinical development bit.ly/3nnrbGv @KSainiMD @curijoey

#LineOfTherapy in Oncology Practice being elegantly presented by dear colleague and friend @KSainiMD for #ESMO22 !

“Feeling hot hot hot!” #Cambridge #globalwarming #climatechange

Self/evident to most, but ignored by those who need to know this fact the most.

Having trouble counting "Lines of Therapy" in a standardized way across all solid #cancers? Here is some guidance: nature.com/articles/s4141… @OncoAlert @BrJCancer @NaturePortfolio

25+ quality papers & reviews converge on the fact that increasing natural light exposure (especially in first 1-3 hrs of the day) + limiting bright artificial light 10pm-4am can improve mood, offset myopia, improve glucose tolerance, testosterone, estrogen and melatonin profiles.

Investment in #Science counts. A data snapshot of China, India and US in @the_hindu today. 🔴 What does this mean for India in the years ahead ? Would like to hear your thoughts.

DYK: Shift in Lung cancer staging in COVID likely 'increase in lung cancer mortality in the next few months and years, as consequence of stage shift at diagnosis associated with the COVID-19 pandemic'. tlcr.amegroups.com/article/view/6…

Preventing infections during cancer therapy can be troublesome at times. However, appropriate precautions may be helpful in preventing them. Useful tips from cdc.gov/cancer/prevent… #cancersurvivormonth

DYK: Cancer is one of the foremost causes of 'Financial toxicity is a term used to describe the harmful effect of high cost of treatment on a person’s quality of life. It may also be described as financial burden or financial distress.' @ChipFoundation jamanetwork.com/journals/jamao…

Finally it’s time for the #DESTINYbreast04 trial at #ASCO22 plenary session: so excited to be in the 2nd row of this big room to see such unprecedented results in the #BreastCancer field...this will remain one of the most important moment in the history of this disease @OncoAlert

@aftimosp @E_de_Azambuja See you both soon in Chicago!

We are back in business! Boarding soon with @E_de_Azambuja to Chicago and #ASCO22

Calling all our friends and colleagues to consider making the Springer journal Oncology and Therapy a home for your manuscripts. Friendly and responsive editorial team! Quick peer review decision. PubMed indexed. Open Access. @OncoAlert @SpringerNature @Oncology_Ther

< 50% of cancer meds on the WHO model list of essential medicines are currently available in LMICs. Needless to say it costs lives.Proud to be part of the leadership of UICC to spearhead efforts to address this challenge . “ATOM”launch Sunday in Geneva .

Fun fact! The name Ki67 derived from the city of Kiel (Ki) where the antibody was produced in the university department of pathology and refers to the number of the original clone (67). #Ki67

We represent one of the most trusted professions in the world! That comes with tremendous responsibility.. nejm.org/doi/full/10.10… @NEJM @OncoAlert

@choo_ek Big Panda and Tiny Dragon

@cspramesh Indeed! Belgium (population 11 million which is half of Mumbai) has three official languages.

Why do we need "ONE" national language?

Incredibly excited to share our paper ‘Somatic mutation rates scale with lifespan across mammals’ now published @nature. nature.com/articles/s4158… An illustrated & updated tweetorial… [1/24]